Medication | Addiction Professional Magazine Skip to content Skip to navigation

Medication

Professionals weigh responses to re-emergence of stimulants

December 7, 2017  |  Gary A. Enos, Editor
blog
Readers discuss whether and how the community will respond to signs of a growing cocaine/stimulant crisis.

FDA approves once-monthly injectable buprenorphine product

December 1, 2017  |  Tom Valentino, Senior Editor
article
The FDA has approved a once-monthly injectable form of buprenorphine for the treatment of opioid use disorder, but clinicians are lukewarm on its use.

Cost analysis backs immediate access to agonist drugs for opioid dependence

November 29, 2017  |  Gary A. Enos, Editor
article
A cost-effectiveness analysis using California data makes a strong case for significant public investment in methadone and buprenorphine treatment.

FDA seeks to encourage development of abuse-deterrent opioid formulations

November 24, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) this week announced several steps designed to remove barriers to access to abuse-deterrent formulations of opioids.

Drug studies' results make case for access to all opioid dependence medications

November 16, 2017  |  Gary A. Enos, Editor
article
Recent efficacy and safety studies found comparable and encouraging results for buprenorphine and injectable naltrexone in the treatment of opioid dependence.

FDA clears electrical device to combat opioid withdrawal

November 15, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) today announced that an electrical stimulation device attached to the ear can be marketed for the treatment of symptoms of opioid withdrawal.

Hospital boosts opioid patients' rapid access to medication

November 14, 2017  |  Gary A. Enos, Editor
article
The experience of Boston Medical Center bolsters evidence that hospitalized patients with opioid use disorders can be successfully initiated on medication before discharge.

Vermont treatment effort gets assist from across the border

November 3, 2017  |  Gary A. Enos, Editor
news
A Massachusetts outpatient treatment facility that offers methadone and injectable naltrexone for opioid dependence has begun accepting Vermont Medicaid patients.

Injectable buprenorphine moves closer to approval

November 2, 2017  |  Gary A. Enos, Editor
news
It appears likely that the first monthly injectable formulation of buprenorphine to treat opioid dependence will receive federal approval by the end of this month.

Addiction program uses team approach, medication to assist pregnant women

October 30, 2017  |  Gary A. Enos, Editor
article
The VCU Health Obstetrical Addiction Program in Virginia is working to improve maternal and child outcomes and to diminish stigma toward the pregnant patient.

Fact sheet on opioid treatments targets justice officials

October 27, 2017  |  Gary A. Enos, Editor
article
The American Association for the Treatment of Opioid Dependence (AATOD) seeks to separate ideology from evidence in discussing the importance of medication treatments in the justice system.

Vermont groups choose unusual venue for messaging on opioid crisis

October 17, 2017  |  Gary A. Enos, Editor
blog
A stigma-busting campaign focusing on opioid addiction is being launched out of the terminal in the Burlington, Vt., airport.

Pages

Subscribe to Medication